Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14120-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14120-1-AP, RRID:AB_2206028
- Product name
- TPPII antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated TPPII antibody (Cat. #14120-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IF, IHC, IP, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references The Activation State of CD4 T Cells Alters Cellular Peptidase Activities, HIV Antigen Processing, and MHC Class I Presentation in a Sequence-Dependent Manner.
Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen.
Novel protein-protein interactions of TPPII, p53, and SIRT7.
Tripeptidyl Peptidase II Is Required for c-MYC-Induced Centriole Overduplication and a Novel Therapeutic Target in c-MYC-Associated Neoplasms.
Boucau J, Madouasse J, Kourjian G, Carlin CS, Wambua D, Berberich MJ, Le Gall S
Journal of immunology (Baltimore, Md. : 1950) 2019 May 15;202(10):2856-2872
Journal of immunology (Baltimore, Md. : 1950) 2019 May 15;202(10):2856-2872
Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen.
Vigneron N, Ferrari V, Van den Eynde BJ, Cresswell P, Leonhardt RM
Journal of immunology (Baltimore, Md. : 1950) 2018 Oct 1;201(7):1875-1888
Journal of immunology (Baltimore, Md. : 1950) 2018 Oct 1;201(7):1875-1888
Novel protein-protein interactions of TPPII, p53, and SIRT7.
Nahálková J
Molecular and cellular biochemistry 2015 Nov;409(1-2):13-22
Molecular and cellular biochemistry 2015 Nov;409(1-2):13-22
Tripeptidyl Peptidase II Is Required for c-MYC-Induced Centriole Overduplication and a Novel Therapeutic Target in c-MYC-Associated Neoplasms.
Duensing S, Darr S, Cuevas R, Melquiot N, Brickner AG, Duensing A, Münger K
Genes & cancer 2010 Sep;1(9):883-92
Genes & cancer 2010 Sep;1(9):883-92
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Jurkat cells were subjected to SDS PAGE followed by western blot with 14120-1-AP(TPP2 antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using TPP2 antibody 14120-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human gliomas using 14120-1-AP(TPP2 antibody) at dilution of 1:100 (under 40x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human gliomas using 14120-1-AP(TPP2 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue